Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.68 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | DNM1 | Q05193 | 9/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrazine SCHEMBL28638493 | 0.97 | — | — | |
| Methylamine SCHEMBL27583441 | 0.94 | TSHR (0.68) | TSHRTHRBDNM1ALDH1A1MEN1 | |
| SCHEMBL2154283 | 0.94 | TSHR (0.77) | TSHRTHRBDNM1ALDH1A1MEN1 | |
| SCHEMBL11095447 | 0.94 | TSHR (0.77) | TSHRTHRBDNM1ALDH1A1MEN1 | |
| Palmitonitrile SCHEMBL17183997 | 0.94 | TSHR (0.77) | TSHRTHRBDNM1ALDH1A1MEN1 | |
| SCHEMBL60342 | 0.94 | TSHR (0.77) | TSHRTHRBDNM1ALDH1A1MEN1 | |
| Heptane SCHEMBL3240570 | 0.94 | TSHR (0.77) | TSHRTHRBDNM1ALDH1A1MEN1 | |
| Octane SCHEMBL6002112 | 0.94 | TSHR (0.77) | TSHRTHRBDNM1ALDH1A1MEN1 | |
| Octane SCHEMBL20497305 | 0.94 | TSHR (0.77) | TSHRTHRBDNM1ALDH1A1MEN1 | |
| SCHEMBL181158 | 0.94 | TSHR (0.77) | TSHRTHRBDNM1ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113574041-A | Method for producing bisphenol and method for producing polycarbonate resin | 三菱化学株式会社 | 2021-10-29 | — | — | CN | disclosed |